Albete, Zyvonna Red S.
HRN: 21-63-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
08/01/2024
08/04/2024
PO
3 Ml
Q12hrs
Urinary Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes